Double Helix Venture Fund

We are thrilled to announce that, through our Double Helix Venture Fund, we have invested in Baigene

We are thrilled to announce that, through our Double Helix Venture Fund, we have invested in Baigene (www.baigene.com). 🚀 This investment is a natural step in a relationship that began some time ago. We had the privilege of supporting the founders in creating the Baigene Method, a globally pioneering methodology. Now, we are going further by joining the founding team and providing the capital needed to scale their business across Spain and, subsequently, worldwide. Why Baigene? Because they are redefining the future of personalized health.Baigene is the first company in the world with more than 2,000 clients who have improved their performance, health, and well-being through a deep understanding of their genetics. Their proprietary genetic test, unique in the market, is used by elite professional athletes as well as by people seeking healthier, more active aging. Their approach is revolutionary. The Baigene Method, protected by the company, goes far beyond genetic analysis. It integrates these scientific insights with monthly tracking of metabolic expression to design fully personalized training and nutrition plans. The result is measurable and lasting improvements in clients’ health and performance. 🧬 We firmly believe Baigene is not just a company; it is the birth of a new category that unites sports genetics with preventive health. They are tackling a massive global opportunity, building from the Basque Country and Spain a company with the potential to become a worldwide reference.At Double Helix, supporting companies like Baigene is part of our DNA. We are inspired by their vision, scientific rigor, and the real-world impact they are already creating. We are convinced this is just the beginning of an incredible journey.We invite investors, institutions, and potential partners to connect with us. Double Helix will continue to make similar investments in our target sectors. Visit www.doublehelix.vc to learn more about our investments and join us. Together, we can take health to the next level.

Why Invest in Life Science and Health Tech Companies in Spain

Why Invest in Life Science and Health Tech Companies in Spain Spain is fast emerging as one of the most exciting destinations for life science investment in Europe. With its impressive healthcare system, top rankings in science and biotechnology, a favorable legal framework for R&D, and a highly skilled yet cost-efficient talent pool, Spain offers unparalleled opportunities for creating and scaling up companies in the health tech and life sciences sectors. If you’re an investor, healthcare innovator, or a tech startup seeking to scale up, this blog will explore why Spain should be the next destination on your radar. A High-Quality and Integrated Healthcare System Spain’s healthcare system is nothing short of a global benchmark. Ranked 8th in the world and 4th in Europe by multiple healthcare indices, it provides a robust foundation for innovation and medical advancements. A Network of Innovative Hospitals and Collaborative Projects Spain boasts over 800 hospitals, with nearly 40% being public and 60% private. What makes the healthcare ecosystem here unique is the high level of collaboration between hospitals, research institutes, and universities. This seamless interaction facilitates groundbreaking medical research and high-quality care. For example, Spanish hospitals are deeply involved in research projects with companies and R&D centers that leverage cutting-edge technologies like AI for early disease detection and personalized medicine. These collaborations create fertile ground for health tech startups and life science companies looking to pilot their innovations in real-world environments. Leading the World in Scientific Contributions Spain continues to punch above its weight when it comes to its contributions to international scientific advancements. 10th Global Scientific Power Spain is ranked as the 10th scientific power globally and holds 3rd place in scientific production within the EU15. This remarkable output reflects the nation’s commitment to research excellence across disciplines, including healthcare and biotechnology. When it comes to biotechnology production specifically, Spain ranks 9th in the world, accounting for 2.5% of the world’s output in biotechnology. Investments in Spain mean entering a collaborative ecosystem that actively contributes to advancements in fields like genomics and biopharmaceuticals. Europe’s Top Country for Clinical Testing Clinical trials are a vital step in bringing innovative treatments to market, and Spain has firmly established itself as Europe’s leader in this field.A Hub for International Clinical Trials Spain collaborates in nearly 20% of all international clinical trials. One out of every three trials conducted in Europe is carried out in a Spanish hospital. Each year, over 1,000 new clinical trials are initiated across the country. For investors and health tech companies, Spain offers significant advantages: Clinical trials represent 60% of pharma investment in Spain. Spanish research hospitals are highly experienced, providing reliable and efficient data for international studies.   Spain was the first EU country to adopt the European Clinical Trials Regulation, reinforcing its forward-thinking approach to healthcare innovation. These elements create low barriers to entry for companies looking to conduct clinical trials, from early-stage to late-phase studies. A Favorable Legal Framework for R&D Activities Spain doesn’t just welcome innovation—it actively incentivizes it. Its favorable legal framework for research and development is designed to attract investors and encourage companies looking to scale up in health tech and life sciences. Significant Tax Incentives Companies can qualify for tax rate deductions of up to 42% for R&D activitiess Additionally, there’s up to a 12% deduction for innovation projects. Supporting R&D Talent Businesses in Spain can take advantage of a 40% deduction in social security contributions for workers employed specifically in R&D roles. These incentives make it easier for startups and established firms to attract top talent and fuel innovation. Affordable and Highly Skilled Talent Pool Talent is the backbone of any innovative industry, and Spain offers one of the most attractive workforces globally. Cost-Effective Expertise The cost of engineering and biotechnology professionals in Spain is 2 to 3 times lower than in other global innovation hubs like Boston, San Francisco, or Cambridge. This allows startups and companies to scale up quickly while maintaining lean operational costs. Rich Pool of Experts Thanks to the country’s renowned universities and research institutions, Spain produces a steady stream of highly skilled professionals in biology, data science, and healthcare. This makes it an exceptional location for building dynamic, multidisciplinary teams capable of driving innovation forward.The Unmet Need for Specialized Private Investors Despite Spain’s stellar framework for life sciences and health tech, there remains one glaring untapped opportunity—the country lacks private specialists exclusively dedicated to scaling companies in these sectors. Many health tech startups face challenges in scaling their innovations to global markets. This presents a golden opportunity for private investors who specialize in life sciences to step in and provide the expertise, mentorship, and capital required to create industry champions. By investing in Spain’s health tech ecosystem and working directly with startups, investors can play an instrumental role in unlocking global growth and innovation from this thriving hub. Why Now is the Time to Invest Spain is poised to be at the forefront of health tech advancements in Europe. With its unique combination of a world-class healthcare system, cutting-edge scientific endeavors, strong clinical trial capabilities, supportive R&D framework, and cost-effective talent pool, the country has all the ingredients to become a major global player. For investors and startups looking for a strategic location to create, innovate, and scale up, Spain offers more than just opportunities—it offers a competitive advantage. Are you ready to create the next big breakthrough in health tech? Explore Spain’s life science opportunities today and connect with the world-class talent and resources that make it possible. Ref: https://www.investinspain.org/en/industries/life-sciences